Support
Take part in the next chapter.
Join a clinical trial, support the research, or write to the team. Every path helps move therapies from the laboratory to patients.
Take part
Two ways to move the science forward.
As a patient in an early feasibility study, or as a donor behind the next one — both start with a conversation.
Patients
Join a trial
Early feasibility studies at CHUV evaluate implantable neurotechnologies for spinal cord injury, Parkinson’s disease and stroke.
- Register your interest below
- Eligibility conversation with the study team
- Assessment at CHUV, Lausanne
Philanthropy
Support our research
Donations help fund the work that grants do not cover yet. Online giving link to be confirmed with the client.
- Preclinical discovery at EPFL
- Device development and testing
- Clinical translation at CHUV
Contact
Write to us
Campus Biotech · Chemin des Mines 9 · 1202 Geneva, Switzerland.
- Generalsupport@neurorestore.swiss
- Presspress@neurorestore.swiss
- CareersSee open positions
- TrialsJoin a trial
Disclaimer
Information on this website is provided for general communication about NeuroRestore research and clinical programmes. It does not constitute medical advice and should not be used to make personal treatment decisions. Clinical trial eligibility is assessed solely by the investigating clinical team.
Privacy
We process personal data only for the purpose for which it is provided (enquiries, trial interest, press or applications). A full privacy notice will replace this stub before launch. Prototype forms on this site do not transmit data.